1606401

Rufinamide

United States Pharmacopeia (USP) Reference Standard

• 别名: 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide
• 经验公式（希尔记法）: C₁₀H₈F₂N₄O
• CAS号: 106308-44-5
• 分子量: 238.19
• MDL號碼: MFCD00865314
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329751064
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: rufinamide
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 格式: neat
• SMILES 字串: NC(=O)c1cn(Cc2c(F)cccc2F)nn1
• InChI: 1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)
• InChI 密鑰: POGQSBRIGCQNEG-UHFFFAOYSA-N
• 基因資訊: human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Rufinamide USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Rufinamide Tablets

生化／生理作用

Broad-spectrum anticonvulsant.

診斷意義

Effective therapy for partial seizures in adults and childhood seizures in Lennox-Gastaut syndrome.

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS08,GHS07
• 訊號詞: Warning
• 危險聲明: H336,H351,H361fd
• 防範說明: P202 - P261 - P271 - P280 - P304 + P340 + P312 - P308 + P313
• 危險分類: Carc. 2 - Repr. 2 - STOT SE 3
• 標靶器官: Central nervous system
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable